Floatz logo

Levosimendan

Sub-arachnoid Haemorrhage

Assistance Publique - Hôpitaux de ParisSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Sub-arachnoid Haemorrhage cohort.

Asset / SponsorPhaseRating
PROPOFOL
Azienda Ospedaliera San Gerardo di Monza
Phase 4BB
ISOFLURANE
Azienda Ospedaliera San Gerardo di Monza
Phase 4BB
DICLOFENAC
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Phase 4BB
Dabigatran
University of Edinburgh
Phase 3BB
Rivaroxaban
University of Edinburgh
Phase 3BB

View all 24 →

Same molecule, other indications

Levosimendan is also rated in:

transient ischemic attackDormant
B
Indicative ·
57 / 100
View asset →
amyotrophic lateral sclerosisDormant
B
Indicative ·
57 / 100
View asset →
stroke disorderDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →